AN2 Therapeutics, Inc
UnclaimedPharmaceutical Preparation ManufacturingMenlo Park, CA
Founded
2017
Primary NAICS
325412
CAGE code
822Z2
Federal awards
$9.2M
Overview
AN2 Therapeutics develops breakthrough medicines through our boron chemistry platform, advancing therapies for infectious diseases and cancer worldwide.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $0 | 3 |
| 2025 | Department of Health and Human Services | $456,766 | 2 |
| 2024 | Department of Health and Human Services | $3,821,365 | 4 |
| 2023 | Department of Health and Human Services | $651,041 | 2 |
| 2022 | Department of Health and Human Services | $4,306,405 | 1 |